Navigation Links
Codexis, Arch Announce Expanded Collaboration
Date:8/25/2008

REDWOOD CITY, Calif. and MUMBAI, India, Aug. 25 /PRNewswire/ -- Codexis, Inc., a leader in biocatalysis technology, and Arch Pharmalabs Limited, a leading Indian active pharmaceutical ingredients (APIs) and intermediates manufacturer, today announced a major new strategic collaboration, expanding their three-year partnership in pharmaceuticals manufacturing.

Codexis, based in Redwood City, CA, will offer multiple pharmaceutical intermediates and active pharmaceutical ingredients (APIs) made with its proprietary biocatalytic processes to both innovator and generic drug manufacturers. Sales in India will be through its subsidiary, Codexis Laboratories India Private Limited. Arch, which is based in Mumbai, India and has ten facilities throughout the country, will be Codexis' exclusive manufacturer for these products. The two companies will also co-market products.

"Codexis and Arch will now offer a broad range of competitively-priced drug ingredients to the global pharmaceutical industry. We believe this collaboration offers a major opportunity for growth," said Alan Shaw, Ph.D., President and Chief Executive Officer of Codexis. "Market drivers for both the innovator and generics sectors of the global pharmaceutical market are converging, as both sectors accelerate their search for high quality manufacturing at the lowest possible cost. This new agreement is targeted at addressing this convergence, coupling proven biocatalysis technology with large-scale manufacturing capability. We are very pleased to be broadening our collaboration with Arch, which has become an important strategic partner."

"Codexis and Arch have built a successful partnership over three years based on anticipating customer needs and consistently meeting them in the rapidly-growing global market for high quality, low-cost pharmaceutical intermediates and APIs," said Ajit Kamath, Chairman and Managing Director, Arch Pharmalabs Limited. "We are now well-positioned to build
'/>"/>

SOURCE Codexis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Codexis, Inc. Files Registration Statement for Proposed Initial Public Offering
2. Anthill Technologies Announces Agreement With Zafgen
3. Baxter Announces Licensing Agreement for Innocolls Gentamicin Surgical Implant in the United States
4. Cell Therapeutics, Inc. Announces Reverse Stock Split
5. Angiotech Announces Extension of the Expiration Date of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
6. Regenesis Biomedical Announces Additions to Board of Directors
7. Cryo-Cell International and EndGenitor Technologies Announce Research Collaboration
8. BioMarin Announces Roll-Out of National PKU Registry
9. Bioheart, Inc. Announces Additional Funding Support
10. Biopure Announces 2008 Third Quarter Financial Results
11. Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... a new microscopy technology that allows them to ... resolution. , Dubbed "Complementation Activated Light Microscopy" (CALM), ... an order of magnitude finer than conventional optical ... biomolecules at the nanometer scale. , In a ... Communications , the researchers behind CALM used it ...
(Date:9/18/2014)... Silicon-valley Electronic Data Capture (EDC) provider ... the latest addition to Clinovo’s CRO Partnership Program. With ... Program, Clinovo further expands its global reach to Latin ... we are now able to build studies on our ... also rely on Clinovo to fully support the solution ...
(Date:9/18/2014)... Whitehouse Laboratories is pleased to announce that ... has acquired an additional 4,000 square feet of dedicated ... adjacent to its current package testing facility. The official ... Whitehouse Labs is in the process of upgrading the ... testing. The prime location enables Whitehouse Labs to immediately ...
(Date:9/17/2014)... LONDON , Sept. 17, 2014 The global ... Tons by 2019. Squalene is a natural skin-identical chemical that ... & personal care, food supplements, pharmaceuticals, and in other applications ... The squalene market has a few major players and is ... (U.S.), Kishimoto Special Liver Oil Co. Ltd. ( Japan ...
Breaking Biology Technology:Scientists pioneer microscopy technique that yields fresh data on muscular dystrophy 2Digitaliza TXT Joins Clinovo’s CRO Partnership Program, Bringing Its Open Source EDC System, ClinCapture to Latin America 2Digitaliza TXT Joins Clinovo’s CRO Partnership Program, Bringing Its Open Source EDC System, ClinCapture to Latin America 3Whitehouse Labs Announces Package Testing Laboratory Expansion 2Whitehouse Labs Announces Package Testing Laboratory Expansion 3Whitehouse Labs Announces Package Testing Laboratory Expansion 4Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 2Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 3
... an effort to spur entrepreneurship in a broader range ... has named the University of Wisconsin-Madison as ... has received $5 million to help train students in ... in 2004 to bring entrepreneurship education to a wider ...
... to provide end-to-end approach to retail workforce optimization ... and the Denver-based StorePerform Technologies, Inc. , ,The ... in the next 20 to 30 days. Financial terms were ... part of RedPrairie's retail productivity division, previously known as ...
... this is my last article of the year, and I have ... my New Year's resolution for this column is bring back more ... is that I simply have not gone to as many concerts ... will need to remedy!) , ,Looking over 2006, my focus has ...
Cached Biology Technology:UW gets $5M to extend entrepreneurship 22006: A great biotech financing year, unless you were going public! 22006: A great biotech financing year, unless you were going public! 32006: A great biotech financing year, unless you were going public! 42006: A great biotech financing year, unless you were going public! 5
(Date:9/17/2014)... EC-FP5 four-year project, delivering its first release in 2004. ... in several EC projects, as a part of the ... BON), to increase the general awareness of the work ... dissemination of the Fauna Europaea results, the ... e-Publishing tools to prepare data papers for all 56 ...
(Date:9/17/2014)... Copenhagen Centre for Social Evolution and Yale University offers ... weight and -length can partially predict the likelihood of ... and schizophrenia later in life. The study analyzed medical ... diagnoses for up to 30 years, and adjusted for ... published today in the Proceedings of the Royal ...
(Date:9/17/2014)... EAST LANSING, Mich. Mutations in the human retinoblastoma ... Now, Michigan State University scientists have turned to fruit ... cancer gene. , In a paper featured on ... Journal of Biological Chemistry , Michigan State University researchers ... mutations similar to those present in the human cancer ...
Breaking Biology News(10 mins):Contributions on Fauna Europaea: Data papers as innovative model on expert involvement 2Size at birth affects risk of adolescent mental health disorders 2Size at birth affects risk of adolescent mental health disorders 3Abnormal properties of cancer protein revealed in fly eyes 2
... , This news release is available in ... diseases like Parkinson,s disease involve the death of thousands of neurons ... as GDNF, promote the survival of the neurons; however, clinical tests ... the Max Planck Institute of Neurobiology in Martinsried and their colleagues ...
... year around 11 million people suffer severe burns. The resulting ... results in lifelong scars. What is needed to reduce this ... Only a very limited area of skin can be removed ... new wounds. Besides conventional skin grafting, another option is to ...
... synthetic biology will be established in Bristol, Nottingham ... from the Biotechnology and Biological Sciences Research Council ... Council (EPSRC). The 40M+ investment will be ... David Willetts tonight at a BBSRC event in ...
Cached Biology News:Parkinson gene: Nerve growth factor halts mitochondrial degeneration 2Parkinson gene: Nerve growth factor halts mitochondrial degeneration 3Blood and lymphatic capillaries grown for the first time in the lab 2UK establishes 3 new synthetic biology research centers 2
Purified Mouse anti-Hu LAT (pY226) Storage Temperature: Refrigerate(2 to 8C)...
Component in MasterPure™ Purification Kits...
Human Cell Line Slides...
Chicken polyclonal to YebU ( Abpromise for all tested applications). Antigen: Full length YebU (Escherichia coli)...
Biology Products: